Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 88053 · Class III · New York Blood Center, Inc.
Key facts
| Event ID | 88053 |
|---|---|
| Recall numbers | B-0468-2021 |
| Recalling firm | New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis product identified as unsuitable due to a labeling deviation, was distributed. |
| Initiation date | Apr 27, 2021 |
| Report date | Jun 23, 2021 |
| Termination date | Jun 14, 2021 |
| City | Long Island City |
| State | NY |
| Country | United States |
| FEI number | 2473015 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: